PIONEERING ANTI-TUMOR IMMUNE REDIRECTION

 OUR GLOBAL TECHNOLOGY PLATFORM

Virus-inspired Particles (ViPs)

We have developed a proprietary Virus-inspired Particle (ViP™) platform technology that can be used as a delivery system to target and treat numerous diseases.

Our ViP Technology Engine Platform employs a proprietary approach based on the natural virology of papillomaviruses. This leads to the systematic and rapid optimization our ViP capsid structure for improved targeting (to different tissues), maximize payload size, reduce immunogenicity and increase manufacturability, all of which could create many additional different platform delivery medicines with huge medical transformative potential

 
 

Our FIRST breakthrough solution

Anti-tumor Immune Redirection

VerImmune's AIR-ViP™ Technology Platform is designed to treat cancer by harnessing the body's immune memory against pathogens and childhood vaccines

 

What makes us different? 

 

 
1-tight.jpg
 

TUMOR TYPE AGNOSTIc SYSTEMIC APPROACH

AIR platform possesses natural tropism for tumors

 
2-tight.jpg
 

multiple avenues for clinical implementation

Functional as a monotherapy with potential as a combination

 
3-tight.jpg
 

Differentiated mechanism of action

Anti-tumor immune redirection is not dependent on PD-1/PD-L1 biology

 
4-tight.jpg
 

Unique clinical biomarker advantage

Select patients with pre-existing memory to vaccine or injection prior to treatment

 

Selected Publications

 
group.jpg